In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Pharmacology

• Publication date

  1999-04-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-2999(99)00120-XPMID 10357258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

  1997cited by this paper
• CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

  1996cited by this paper
• A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity.

  1996cited by this paper
• Appetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide

  1996cited by this paper
• 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.

  1996cited by this paper
• In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.

  1996cited by this paper
• Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.

  1995cited by this paper
• Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

  1995cited by this paper
• Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats.

  1995cited by this paper
• Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

  1995cited by this paper
• Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats.

  1995cited by this paper
• CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues.

  1995cited by this paper
• Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior

  1994cited by this paper
• Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.

  1994cited by this paper
• Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

  1994cited by this paper
• Corticotropin‐releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat

  1994cited by this paper
• Expression cloning of a human corticotropin-releasing-factor receptor.

  1993cited by this paper
• Physiology and pharmacology of corticotropin-releasing factor.

  1991cited by this paper
• Regulation of ACTH secretory pathways in cultured pituitary cells.

  1991cited by this paper
• Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

  1990cited by this paper
• CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice.

  1989cited by this paper
• SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat

  1988cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion.

  1986cited by this paper
• Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.

  1984cited by this paper
• Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3',5'-monophosphate in cultured anterior pituitary cells.

  1983cited by this paper
• Corticotropin releasing factor stimulates adrenocorticotropin and beta-endorphin release from AtT-20 mouse pituitary tumor cells.

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I

  1966cited by this paper

• Corticotropin-releasing factor receptors in GtoPdb v.2025.3

  2025cites this paper
• Corticotropin-releasing factor receptors in GtoPdb v.2023.1

  2023cites this paper
• Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders.

  2021cites this paper
• Corticotropin-releasing factor receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models.

  2010cites this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cites this paper
• 2-Arylpyrimidines: novel CRF-1 receptor antagonists.

  2008cites this paper
• The design, synthesis and structure-activity relationships of 1-aryl-4-aminoalkylisoquinolines: a novel series of CRF-1 receptor antagonists.

  2008cites this paper
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cites this paper
• The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists.

  2006cites this paper
• Corticotropin-releasing factor

  2006cites this paper
• Can CRF1 receptor antagonists become antidepressant and/or anxiolytic agents?

  2005cites this paper
• Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats

  2004influential citation
• Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450.

  2004cites this paper
• SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats.

  2004cites this paper
• Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.

  2004cites this paper
• Sexual differentiation of the effects of emotional stress on food intake in rats.

  2004cites this paper
• Guide to Receptors and Channels, 1st Edition

  2004cites this paper
• Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor

  2003influential citation
• Corticotropin-releasing factor as well as opioid and dopamine are involved in tail-pinch-induced food intake of rats.

  2003cites this paper
• 2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists.

  2003cites this paper
• Synthesis of [N‐methyl‐11C]‐3‐[(6‐dimethylamino)pyridin‐3‐yl]‐2,5‐dimethyl‐N, N‐dipropylpyrazolo[1,5‐a]pyrimidine‐7‐amine: A potential PET ligand for in vivo imaging of CRF1 receptors

  2003cites this paper
• The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review.

  2003cites this paper
• 3-Aryl pyrazolo[4,3-d]pyrimidine derivatives: Nonpeptide CRF-1 antagonists.

  2002cites this paper
• Role of CRF(1) and CRF(2) receptors in fear and anxiety.

  2001cites this paper
• CRHR1 Antagonists as Novel Treatment Strategies

  2001cites this paper
• The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.

  2001cites this paper
• Expression of Corticotropin-Releasing Hormone Type 1 Receptor in Paraventricular Nucleus after Acute Stress

  2001cites this paper
• Corticotropin releasing hormone stimulates proliferation of keratinocytes.

  2001cites this paper
• Effect of non-peptide corticotropin-releasing factor receptor type 1 antagonist on adrenocorticotropic hormone release and interleukin-1 receptors followed by stress.

  2001cites this paper
• Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor1 receptor antagonists.

  2000cites this paper
• Selective Corticotropin‐Releasing Factor Type 1 Receptor Antagonist Blocks Conditioned Fear‐Induced Release of Noradrenaline in the Hypothalamic Paraventricular Nucleus of Rats

  2000cites this paper
• Corticotropin-releasing factor antagonists in affective disorders.

  1999cites this paper
• Role of the angiotensin II type-2 receptor in the mouse central nervous system.

  1999cites this paper
• Corticotropin-Releasing Factor Antagonists

  1999cites this paper